INLB OTC
Item 9 Labs Corp.
1W: -99.0%
1M: -99.0%
3M: -99.0%
YTD: -99.0%
1Y: -99.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±4955.7%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.1M
52W Range0.0001-0.0001
Volume20,000
Avg Volume20,520
Beta0.14
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJeffrey I. Rassas
Employees97
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2012-01-25
Websiteitem9labscorp.com
2727 North 3rd Street
Phoenix, AZ 85004
US
Phoenix, AZ 85004
US
833 867 6337
About Item 9 Labs Corp.
Based in the United States, Item 9 Labs Corp. operates as a comprehensive cannabis company, encompassing both vertical integration in cannabis operations and the franchising of dispensaries. The firm produces a wide spectrum of cannabis and related goods, such as raw flower, various concentrates, distillates, and necessary hardware. These cannabis and derived technologies and products are then supplied to consumers in Arizona via licensed retail dispensaries. Complementing its production activities, the company also develops and offers medical and adult-use cannabis dispensary franchises under its distinct Unity Rd brand. The main office for Item 9 Labs Corp. is found in Phoenix, Arizona.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Kutscher Eric | 0 | — | 2021-12-14 | |
| Taylor Lawrence X. I | 0 | — | 2021-12-14 | |
| KESKEY MICHAEL P | 0 | — | 2020-07-31 | |
| Bowden Douglas P | 3,500,000 | $1.00 | 2020-04-01 | |
| Bowden Douglas P | 400,000 | $0.05 | 2020-04-01 |